IJCP Editorial Team
Covid Jab Covovax to Be Available On CoWIN as a Heterologous Booster
Given rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya has recently approved registering Serum Institute's Covovax on the CoWIN portal as a heterologous booster dose for adults.
Covovax will be available on the portal in the coming days, priced at nearly ₹225/dose, excluding GST.
This action succeeded a request by Prakash Kumar Singh, Director, Serum Institute of India (SII), to the Union health ministry on 27/03/2023, which stated that Covovax is a world-class vaccine approved by the DCGI, WHO, and USFDA and proposed its inclusion as a heterologous booster vaccine for adults on the CoWIN portal.
IJCP Editorial Team
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
More FAQs by IJCP Editorial Team
Recent FAQs
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article